Peter Honig - 03 Dec 2021 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
Director
Signature
/s/Nancy Smith as Attorney-in-Fact for Peter Honig
Issuer symbol
KPTI
Transactions as of
03 Dec 2021
Net transactions value
$0
Form type
4
Filing time
07 Dec 2021, 09:37:46 UTC
Previous filing
21 Jul 2021
Next filing
20 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPTI Nonstatutory Stock Option (right to buy) Award $0 +47,800 $0.000000 47,800 03 Dec 2021 Common Stock 47,800 $6.72 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on December 3, 2021. The shares underlying the option vest as to one-third (1/3) of the shares on December 3, 2022 and as to the remaining two-thirds (2/3) of the shares in 24 equal monthly installments thereafter.